Latest News for: glp-1

Edit

FILE PHOTO: A consumer injects herself with GLP-1 weight loss drug

Magic Valley 12 Nov 2026
A woman cleans her skin before injecting herself with Zepbound, a GLP-1 weight-loss drug, at her home in Memphis, Tennessee, July 30 ... .
Edit

GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these ...

Caledonian Record 11 Nov 2026
Doctors often call the condition a stroke of the eye – and though the risk is small, patients should know the symptoms and seek immediate treatment if they occur ....
Edit

GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says

CBS News 11 Nov 2026
GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News to discuss ... .
Edit

FDA adds rare vision-loss warning to popular GLP-1 drugs

The Sun Chronicle 11 Nov 2026
WASHINGTON — Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday ... .
Edit

FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning

Business Line 11 Nov 2026
These drugs may be associated with a ...
Edit

Penn State study challenges popular claim that GLP-1s quiet 'food noise'

The Washington Times 11 Nov 2026
A Penn State University study is challenging the claim that GLP-1 medications prescribed for weight loss and Type 2 diabetes quiet the "food noise" that tempts people to overeat ... .
Edit

FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic

Business Line 11 Nov 2026
Indian endocrinologists, ...
Edit

How GLP-1 Drugs and a Revamp Revived Ro’s Business

New York Times 11 Nov 2026
The telehealth company said that its annualized revenue had grown more than tenfold since it revamped its business and embraced weight-loss treatments ... .
Edit

Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs

FX Empire 11 Nov 2026
McKesson Corporation (MCK) shares up over 235% since May 2022 thanks to institutional support ....
Edit

MeAgain Launches the MeAgain Index, Establishing the First Comprehensive Quarterly Benchmark for the GLP-1 Ecosystem

Rutland Herald 11 Nov 2026
NEW YORK--(BUSINESS WIRE)--Nov 11, 2026-- ....
Edit

Healthy eating, GLP-1 trend make air fryers a kitchen staple as sales double

The Times of India 11 Nov 2026
.
Edit

Why Filipino actress and model Isabelle Daza is embracing GLP-1s for more than weight loss

South China Morning Post 11 Nov 2026
“I had gained 70lbs [32kg] during pregnancy, and he came out and weighed 6lbs ... .
Edit

U.S. Medicare's GLP-1 and Telehealth Developments: Select Commercial Stakes for Investors and Manufacturers (Dechert LLP)

Public Technologies 11 Nov 2026
First, the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge Program (the GLP-1 Bridge) on July 1, 2026, giving Medicare Part D beneficiaries ...
Edit

Why are fewer Black Americans getting GLP-1s?

Vox 11 Nov 2026
GLP-1s have become the newest celebrity miracle drug, with famous athletes like Serena Williams and Charles Barkley sharing that they’ve used it for weight loss ... Read more about GLP-1s, diabetes, and race in American medicine..
Edit

GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns

Taipei Times 11 Nov 2026
On Monday, US regulators ordered makers of glucagon-like peptide-1 (GLP-1) drugs — commonly known as weight-loss shots — to add information about increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) to warning labels.

Article Search

tools
×
×
×
×